Table 4.
Name enzyme | E.C number | Model prediction | Experimental data | References |
---|---|---|---|---|
Catalase | EC:1.11.1.6 | Up | Up | Gu et al., 2004; Armogida et al., 2011 |
Superoxide dismutase | EC:1.15.1.1 | Up | Up | Baker et al., 1998 |
Glutathione peroxidase | EC:1.11.1.9 | Up | Up | Weisbrot-Lefkowitz et al., 1998 |
Glyceraldehyde-3-phosphate dehydrogenase | EC:1.2.1.12 | Up | Up | Tanaka et al., 2002 |
Hexokinase | EC:2.7.1.1 | Up | Up | Niitsu et al., 1999 |
Nicotinamide phosphoribosyltransferase | EC:2.4.2.12 | Up | Up | Yamauchi et al., 2001; Wang et al., 2011; Jing et al., 2014; Morris-Blanco et al., 2014 |
Phospholipase A2 | EC:3.1.1.4 | Up | Up | Muralikrishna Adibhatla and Hatcher, 2006 |
Isocitrate dehydrogenase | EC:1.1.1.42 | Down | Down | Grelli et al., 2013 |
Monoamine oxidase | EC:1.4.3.4 | Down | Down | Khvatova et al., 1997, 2007 |
Overall, in silico predictions of changes in metabolic function are similar to the changes reported experimentally in practices performed in astrocytes submitted to ischemia.